2,076 reports of this reaction
2.4% of all ISOTRETINOIN reports
#6 most reported adverse reaction
PREGNANCY is the #6 most commonly reported adverse reaction for ISOTRETINOIN, manufactured by JG Pharma Inc.. There are 2,076 FDA adverse event reports linking ISOTRETINOIN to PREGNANCY. This represents approximately 2.4% of all 86,016 adverse event reports for this drug.
Patients taking ISOTRETINOIN who experience pregnancy should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PREGNANCY is a less commonly reported adverse event for ISOTRETINOIN, but still significant enough to appear in the safety profile.
In addition to pregnancy, the following adverse reactions have been reported for ISOTRETINOIN:
The following drugs have also been linked to pregnancy in FDA adverse event reports:
PREGNANCY has been reported as an adverse event in 2,076 FDA reports for ISOTRETINOIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
PREGNANCY accounts for approximately 2.4% of all adverse event reports for ISOTRETINOIN, making it a notable side effect.
If you experience pregnancy while taking ISOTRETINOIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.